Responses
Clinical and epidemiological research
Extended report
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
Compose a Response to This Article
Other responses
No responses have been published for this article.